Pixclara Solution
Product Images NDC 74725-338

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pixclara (NDC 74725-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Telix Pharmaceuticals (us) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pixclara 01)

An image of a brain scan showing a labeled lesion of interest indicated by a red arrow and a highlighted region of interest (ROI) outlined in blue with dimensions noted. The scan appears to focus on identifying and measuring specific areas in the brain, likely related to PIXCLARA use.*

FDA Label Image

Figure 2 (Pixclara 02)

A set of two nuclear medicine brain scans labeled A and B showing different patterns of radiotracer uptake. Both images are heat maps with a color scale indicating radiotracer activity intensity, ranging from low (dark colors) to high (white/red). Image A highlights a localized bright area of high uptake on the right side (marked by a red arrow). Image B shows a different region of uptake in the lower part of the brain (marked by a yellow arrow). These scans likely depict the in vivo distribution of the radioactive drug Floretyrosine F18 used in PET imaging.*

FDA Label Image

Chemical Structure (Pixclara 03)

Chemical structure diagram of Floretyrosine F18, the active ingredient in PIXCLARA (300 mCi/mL solution for intravenous use). The structure shows a fluorine-18 labeled ethoxy group attached to a phenyl ring, linked to an amino acid moiety with an amine and carboxylic acid group.*

FDA Label Image

Principal Display Panel (30 mL Vial Label)

Label for PIXCLARA (Floretyrosine F18) injection, a sterile, non-pyrogenic intravenous solution. The label shows a strength range from 185 MBq/mL to 11,100 MBq/mL (5 mCi/mL to 300 mCi/mL) at the end of synthesis, expiring 14 hours after synthesis. It is manufactured for Telix Pharmaceuticals US, Inc. The label includes a caution for radioactive material and states the product is a multiple-dose vial, NDC 74725-338-30, Rx only.*

FDA Label Image

Principal Display Panel (30 mL Multiple-Dose Vial Label)

Label for PIXCLARA (Floretyrosine F18) injection, a sterile intravenous solution with a strength range of 185 MBq/mL to 11,100 MBq/mL (5 mCi/mL to 300 mCi/mL) at the end of synthesis (EOS). The label includes dosage form and storage instructions, radioactive caution symbols, batch, activity, concentration, volume, and expiration fields, and indicates the product is manufactured by Telix Pharmaceuticals US, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.